Related references
Note: Only part of the references are listed.Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
Yang Liu et al.
VIRAL IMMUNOLOGY (2021)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
Yingxia Liu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Yajing Fu et al.
VIROLOGICA SINICA (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients
Fengting Yu et al.
CLINICAL INFECTIOUS DISEASES (2020)
What we know so far: COVID-19 current clinical knowledge and research
Mary A. Lake
CLINICAL MEDICINE (2020)
Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
Markus Depfenhart et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
SARS-CoV-2 was already spreading in France in late December 2019
A. Deslandes et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
Tahir S. Pillay
JOURNAL OF CLINICAL PATHOLOGY (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Virology, Epidemiology, Pathogenesis, and Control of COVID-19
Yuefei Jin et al.
VIRUSES-BASEL (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
Eddy Fan et al.
LANCET RESPIRATORY MEDICINE (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
Francois-Xavier Lescure et al.
LANCET INFECTIOUS DISEASES (2020)
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
Mizuki Yamamoto et al.
VIRUSES-BASEL (2020)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer
Alexandra C. Walls et al.
NATURE (2016)
The host immune response in respiratory virus infection: balancing virus clearance and immunopathology
Amy H. Newton et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells
Mutsuo Yamaya et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2
Kazuya Shirato et al.
JOURNAL OF VIROLOGY (2013)
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2012)
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
Andrew Prussia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease
Jin Kan Sai et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations
Glen Spraggon et al.
PROTEIN SCIENCE (2009)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling
Xingang Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Marcella Martignoni et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients:: relation to the acute lung injury and pathogenesis of SARS
L. He et al.
JOURNAL OF PATHOLOGY (2006)
Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: Is camostat mesilate effective?
N Ashizawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity
K Kono et al.
AMERICAN JOURNAL OF SURGERY (2005)
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection
S Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effect of oral camostat mesilate on hematuria and/or proteinuria in children
T Asami et al.
PEDIATRIC NEPHROLOGY (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β
M Okuno et al.
GASTROENTEROLOGY (2001)
Share Paper
